Divi's Laboratories Limited (NSE: DIVISLAB)

Divi's Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	36,020	3,630	1,700	12,148	20,303	431.5
Short-Term Investments	-	33,350	39,630	15,269	505	110.1
Trading Asset Securities	-	-	-	-	-	9,714
Cash & Short-Term Investments	36,020	36,980	41,330	27,417	20,808	10,255
Cash Growth	-0.25%	-10.53%	50.75%	31.76%	102.91%	-27.34%
Accounts Receivable	21,810	21,560	17,930	24,239	16,765	14,134
Other Receivables	-	2,050	1,410	1,045	1,018	1,856
Receivables	21,810	23,610	19,340	25,283	17,783	15,990
Inventory	31,450	31,840	30,000	28,286	21,452	18,639
Prepaid Expenses	-	360	260	270.9	225	169.7
Other Current Assets	4,130	3,960	2,190	2,258	1,479	1,745
Total Current Assets	93,410	96,750	93,120	83,515	61,747	46,798
Property, Plant & Equipment	59,700	55,130	49,290	47,875	44,095	36,979
Long-Term Investments	850	820	770	720.1	0.1	0.1
Other Intangible Assets	40	40	50	74.9	49.5	36
Long-Term Deferred Tax Assets	150	100	140	144.7	32.3	43.8
Other Long-Term Assets	1,710	1,860	1,020	1,418	1,816	1,146
Total Assets	155,860	154,700	144,390	133,747	107,741	85,357
Accounts Payable	8,550	8,240	7,620	7,957	7,632	5,907
Accrued Expenses	480	2,440	2,550	3,235	2,486	1,889
Short-Term Debt	50	-	-	-	3.5	336.3
Current Portion of Leases	10	10	10	8.2	7.9	7.5
Current Income Taxes Payable	680	430	20	16.8	59.8	99.3
Current Unearned Revenue	-	10	10	7.6	6.4	5.4
Other Current Liabilities	3,140	1,650	800	731.3	929.3	1,024
Total Current Liabilities	12,910	12,780	11,010	11,956	11,125	9,268
Long-Term Leases	20	20	30	28.7	36.9	44.7
Long-Term Deferred Tax Liabilities	5,760	5,820	5,370	4,214	3,381	2,740
Other Long-Term Liabilities	-	370	310	267.1	252.5	205.2
Total Liabilities	18,690	18,990	16,720	16,465	14,795	12,258
Common Stock	530	530	530	530.9	530.9	530.9
Additional Paid-In Capital	-	800	800	798.8	798.8	798.8
Retained Earnings	-	134,120	126,090	115,797	91,480	71,636
Comprehensive Income & Other	136,640	260	250	155.1	136.3	133.9
Shareholders' Equity	137,170	135,710	127,670	117,282	92,946	73,099
Total Liabilities & Equity	155,860	154,700	144,390	133,747	107,741	85,357
Total Debt	80	30	40	36.9	48.3	388.5
Net Cash (Debt)	35,940	36,950	41,290	27,380	20,760	9,867
Net Cash Growth	-0.33%	-10.51%	50.81%	31.89%	110.41%	-24.44%
Net Cash Per Share	135.36	139.19	155.54	103.14	78.20	37.17
Filing Date Shares Outstanding	265.63	265.47	265.47	265.47	265.47	265.47
Total Common Shares Outstanding	265.63	265.47	265.47	265.47	265.47	265.47
Working Capital	80,500	83,970	82,110	71,560	50,623	37,530
Book Value Per Share	516.40	511.21	480.92	441.79	350.12	275.36
Tangible Book Value	137,130	135,670	127,620	117,207	92,897	73,063
Tangible Book Value Per Share	516.25	511.06	480.73	441.51	349.93	275.22
Land	-	1,950	1,940	1,727	1,715	1,611
Machinery	-	48,610	45,770	39,860	33,535	25,292
Construction In Progress	-	7,780	2,120	4,699	7,106	9,197

Source: S&P Capital IQ. Standard template. Financial Sources.